| NCT ID | NCT07539142 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Arkansas |
| Condition | Hospital-based Violence Intervention |
| Study Type | INTERVENTIONAL |
| Enrollment | 208 participants |
| Start Date | 2026-04-20 |
| Primary Completion | 2028-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 208 participants in total. It began in 2026-04-20 with a primary completion date of 2028-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The present study will use an optimization randomized control trial design to test the preliminary efficacy of a Hospital-based Violence Intervention Program (HVIP) in Central Arkansas.
Eligibility Criteria
Inclusion Criteria: * Be at least 18 years of age or older * Currently live in Central Arkansas * Currently being treated for a penetrating gun assault injury at a local hospital Exclusion Criteria: Participants must not: * Report any medical problems that would limit their ability to express thoughts and answer questions (i.e. active intoxication, developmental delays, dementia, psychosis, etc.) * Be currently under arrest or in police custody
Contact & Investigator
Nakita Lovelady, PhD, MPH
PRINCIPAL INVESTIGATOR
University of Arkansas
Frequently Asked Questions
Who can join the NCT07539142 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Hospital-based Violence Intervention. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07539142 currently recruiting?
Yes, NCT07539142 is actively recruiting participants. Contact the research team at nnlovelady@uams.edu for enrollment information.
Where is the NCT07539142 trial being conducted?
This trial is being conducted at Little Rock, United States.
Who is sponsoring the NCT07539142 clinical trial?
NCT07539142 is sponsored by University of Arkansas. The principal investigator is Nakita Lovelady, PhD, MPH at University of Arkansas. The trial plans to enroll 208 participants.